UFP Technologies, Inc. (NASDAQ:UFPT) Position Increased by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. raised its holdings in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 102.3% in the 4th quarter, Holdings Channel reports. The firm owned 3,170 shares of the industrial products company’s stock after purchasing an additional 1,603 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in UFP Technologies were worth $775,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Wasatch Advisors LP grew its position in shares of UFP Technologies by 65.4% during the third quarter. Wasatch Advisors LP now owns 420,549 shares of the industrial products company’s stock worth $133,188,000 after acquiring an additional 166,262 shares during the last quarter. State Street Corp grew its position in shares of UFP Technologies by 1.4% during the third quarter. State Street Corp now owns 283,460 shares of the industrial products company’s stock worth $89,772,000 after acquiring an additional 4,007 shares during the last quarter. Congress Asset Management Co. grew its position in shares of UFP Technologies by 14.2% during the fourth quarter. Congress Asset Management Co. now owns 281,325 shares of the industrial products company’s stock worth $68,787,000 after acquiring an additional 35,022 shares during the last quarter. Geode Capital Management LLC grew its position in UFP Technologies by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 172,996 shares of the industrial products company’s stock valued at $54,799,000 after buying an additional 3,333 shares in the last quarter. Finally, Boston Trust Walden Corp bought a new position in UFP Technologies in the 4th quarter valued at about $26,395,000. Institutional investors own 87.28% of the company’s stock.

Insider Buying and Selling at UFP Technologies

In other UFP Technologies news, Director Daniel C. Croteau sold 6,846 shares of the company’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $228.41, for a total value of $1,563,694.86. Following the completion of the sale, the director now directly owns 1,785 shares of the company’s stock, valued at approximately $407,711.85. This represents a 79.32 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 6.17% of the stock is owned by corporate insiders.

UFP Technologies Stock Performance

Shares of UFPT opened at $220.64 on Friday. The firm has a 50-day moving average price of $253.53 and a 200 day moving average price of $286.13. The firm has a market capitalization of $1.69 billion, a PE ratio of 31.48 and a beta of 1.15. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64. UFP Technologies, Inc. has a 52-week low of $188.50 and a 52-week high of $366.41.

UFP Technologies (NASDAQ:UFPT) last announced its earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.45. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%. The firm had revenue of $144.07 million during the quarter, compared to analyst estimates of $141.67 million.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of UFP Technologies from a “hold” rating to a “sell” rating in a research report on Thursday, January 23rd.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.